This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyer, R.
Right arrow Articles by Schwartz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyer, R.
Right arrow Articles by Schwartz, I.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2001, p. 2954-2957, Vol. 39, No. 8
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.8.2954-2957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Characterization of Borrelia burgdorferi Isolated from Erythema Migrans Lesions: Interrelationship of Three Molecular Typing Methods

Radha Iyer,1 Dionysios Liveris,1 Atoya Adams,1 John Nowakowski,2 Donna McKenna,2 Susan Bittker,2 Denise Cooper,2 Gary P. Wormser,2 and Ira Schwartz1,2,*

Department of Biochemistry & Molecular Biology1 and Division of Infectious Diseases, Department of Medicine,2 New York Medical College, Valhalla, New York 10595

Received 12 February 2001/Returned for modification 8 April 2001/Accepted 13 May 2001


    ABSTRACT
Top
Abstract
Text
References

Genetic diversity among Borrelia burgdorferi isolates recovered from the skin of Lyme disease patients was assessed by ribosomal DNA (rDNA) spacer restriction fragment length polymorphism analysis, genomic restriction site polymorphism analysis, and plasmid content analysis. There was a significant association between the three rDNA spacer types, the six pulsed-field gel types, and plasmid content (P < 0.001). The association between distinct chromosomal and plasmid markers implies a clonal origin for each genotype.


    TEXT
Top
Abstract
Text
References

Lyme disease, a disorder which may affect multiple organ systems, results from infection with the spirochete Borrelia burgdorferi. Between 1989 and 1997, 114,314 cases of Lyme disease were reported to the Centers for Disease Control and Prevention, making Lyme disease the most common vector-borne disease in the United States (16, 21). Early Lyme disease is manifested by a characteristic skin rash, erythema migrans (EM), and is frequently accompanied by systemic symptoms (14, 15). Molecular analysis of B. burgdorferi isolates has resulted in the differentiation of B. burgdorferi sensu lato into 10 distinct species (23). B. burgdorferi sensu stricto is the only known Lyme disease borrelia infecting patients in North America. Significant genetic heterogeneity among B. burgdorferi sensu stricto isolates in North America has been reported (1, 6, 8, 13). The type strain of B. burgdorferi sensu stricto, B31 has a large linear genome of 910,725 bp and 21 linear and circular plasmids with a total size of 610,694 bp (3, 7).

It has long been recognized that the clinical expression of B. burgdorferi infection is diverse (15). Possible explanations for this variability are differences in the genotypes of the infecting strain of B. burgdorferi. We developed a typing method based on restriction fragment length polymorphism (RFLP) in the 16S-23S ribosomal DNA (rDNA) spacer of B. burgdorferi and used it to analyze clinical isolates obtained from early Lyme disease patients (9). A highly significant association was found between the infecting RFLP type in the skin and the presence of spirochetemia or multiple EM lesions (25), suggesting that differences in the clinical presentations of Lyme disease patients may, indeed, be related to B. burgdorferi genotype. rDNA spacer analysis provides genetic typing information for a single genomic locus and interrogates a chromosomal region which is unlikely to have a direct role in pathogenesis. In order to obtain additional, broader typing information, 48 cutaneous isolates from early Lyme disease patients were analyzed by pulsed-field gel electrophoresis (PFGE).

Subjects, skin biopsy, and cultivation. All subjects were adults with EM enrolled in a prospective study at the Lyme Disease Diagnostic Center of the Westchester Medical Center, Valhalla, N.Y. Skin biopsy specimens (2 mm) were obtained from the leading edge of primary EM lesions and cultured in BSK-II medium as described previously (19).

PFGE. Spirochetes were harvested by centrifugation and washed twice with sterile phosphate-buffered saline. The cells were resuspended in 50 mM Tris-HCl-150 mM NaCl (pH 8.0), and an equal volume of 1.8% low-gelling-temperature agarose (SeaPlaque; FMC Corp., Rockland, Maine) was added. The cells, in agarose blocks, were lysed as described previously (5). For plasmid analysis, blocks were washed extensively with 10 mM Tris-HCl-1 mM EDTA (pH 8.0) and PFGE was performed in 0.5× Tris-borate-EDTA at 14°C on a Bio-Rad CHEF DR II electrophoresis system. One percent agarose gels were run at a constant voltage (6 V/cm) for 19 h, with a switch time of 0.7 to 2.2 s. For chromosome restriction fragment analysis, agarose blocks containing B. burgdorferi were incubated overnight at 37°C with 40 to 50 U of MluI in 0.5 ml of 50 mM Tris-HCl (pH 7.5)-10 mM MgCl2-100 mM NaCl-1 mM dithioerythritol. PFGE was performed as described above, except that a switch time of 6 to 25 s was used.

The relative proportions of the three rDNA spacer RFLP types (RSTs) among the 48 isolates (29.2, 41.7, and 29.2% for RST1, RST2, and RST3, respectively) were similar to those for the larger group of cutaneous isolates reported previously (25.1, 38.3, and 30.1% for RST1, RST2, and RST3, respectively) (10). Total genomic DNA was digested with MluI, and the resultant fragments were resolved by PFGE. The results, summarized schematically in Fig. 1, revealed six distinct pulsed-field gel (PFG) patterns. Fifty-two percent (25 of 48) displayed a pattern designated type A. An additional 16.7% (8 of 48) had the pattern designated type B, and 12.5% (6 of 48) showed a type D pattern; the remaining isolates were equally distributed between types C, E, and F. These patterns were all observed in a previous study of representative B. burgdorferi isolates by Mathiesen et al. (13) and are designated here types A to F, after their nomenclature. Of the 65 human isolates characterized in the earlier study, 54 (83%) were PFG type A, which was also the predominant PFG type (52%) among the isolates in the present investigation. Interestingly, PFG type E was observed only in ticks by Mathiesen et al. (13), whereas three PFG type E isolates were detected among the human isolates in the present analysis. Thus, all major North American B. burgdorferi sensu stricto PFG types are found in a narrowly defined geographic location (Westchester County, N.Y.) and are infectious to humans.


View larger version (21K):
[in this window]
[in a new window]
 
FIG. 1.   Schematic representation of six MluI PFG types among B. burgdorferi clinical isolates. The approximate sizes of each fragment (in kilobases) are noted.

The plasmid contents in the same isolates were also analyzed by PFGE. Since repeated culture passage is known to result in selective plasmid loss (2, 18, 20), isolates in the present study were analyzed between passages 2 and 5. Most isolates tested carried all of the plasmids previously identified in strain B31. The most distinctive difference among the isolates discernible by PFGE was the presence or absence of lp38, which was confirmed by Southern blotting with an ospD-specific probe (ospD is encoded on lp38) and by ospD-specific PCR (data not shown). Of the isolates analyzed, 21 (44%) carried a copy of lp38. Palmer et al. (17) recently reported the distribution of 12 linear plasmids in 15 B. burgdorferi sensu stricto isolates by plasmid-specific probe hybridization. These isolates were from a broad geographic distribution; the specimen sources (human, tick, etc.) were not given. They found that lp5, lp21, and lp56 were found in no more than 3 of these isolates, lp17 and lp38 were present in 10 of 15 of the isolates, and the remainder were found in at least 14 of the isolates. The results of the present study are mostly consistent with and extend those of earlier study. A difference between the two studies is the proportion of isolates which carry lp38 (67% [10 of 15] in the study of Palmer et al. [17] and 44% [21 of 27] in the present study [P = 0.12]). Since all the isolates in the present study were obtained from human EM lesions, this indicates that lp38 and its gene products are not required for infectivity.

It was of interest to ascertain whether any correlation exists between the three typing methods applied to this group of isolates. For the purposes of the analysis, the plasmid type (P or N) was based on the presence or absence of lp38. Each technique scores for a specific and seemingly unrelated genotypic character: sequence heterogeneity in a ribosomal spacer, point polymorphisms in restriction sites distributed across the linear chromosome, and the presence or absence of a single linear plasmid. If these genotypic characters were independent, one would expect that all possible combinations would be observed and would occur at equal frequencies among the isolates tested. The data presented in Table 1 and Fig. 2 demonstrate that these characteristics cosegregate with each other at a highly significant rate (P < 0.001). The genotype of any individual isolate could be designated by a combination of the three separate RSTs, PFG types, and plasmid types. For example, an isolate which is RST1, is PFG type B, and contains lp38 would have the designation 1BP. Only 10 of the 36 possible genotypes were observed among the 48 isolates tested; 79% (38 of 48) were one of the four predominant genotypes (1BP, 1DP, 2AN, and 3AN) (Fig. 2).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   RST, MluI PFG type, and plasmid type for 48 B. burgdorferi clinical isolates



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 2.   Association of RST, PFG type, and plasmid type. RST and plasmid types are represented as one of six possible combinations and plotted versus PFG type.

Dykhuizen et al. (4) demonstrated that there is little or no genetic exchange between chromosomal genes in B. burgdorferi and that there is little evidence for plasmid transfer between isolates; on this basis, they concluded that B. burgdorferi is clonal. In a separate study from that group, linkage between ospA and ospC genotypes was observed, even though these genes are encoded on separate plasmids (24). The data presented here are in agreement with those from the earlier studies and support the clonality of B. burgdorferi. Several groups have reported evidence for lateral exchange of plasmid-encoded genes in B. burgdorferi (11, 12, 22). The mechanisms for such gene transfer are not known, but the present data suggest that it does not occur via exchange of entire plasmids between isolates.

We previously reported an association between rDNA spacer RFLP and hematogenous dissemination of B. burgdorferi from skin (25). A limitation of that study was that sequence variation in a rDNA spacer is unlikely to be a determinant of virulence. In the present study, additional unrelated genomic loci were examined by PFGE, and a significant correlation between the results of rDNA spacer typing and those of PFGE typing was observed. Since rDNA spacer typing is a PCR-based method, it does not require cultivation and can be performed rapidly with small quantities of clinical material. The present study establishes that rDNA spacer analysis can serve as an accurate reflection of B. burgdorferi genotype.


    ACKNOWLEDGMENTS

We thank S. Casjens, R. Marconi, S. Norris, J. Purser, and B. Stevenson for providing probes or primer sequences.

This work was supported by Public Health Service grant AR41511 from the National Institutes of Health.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Biochemistry & Molecular Biology, New York Medical College, Valhalla, NY 10595. Phone: (914) 594-4658. Fax: (914) 594-3455. E-mail: schwartz{at}nymc.edu.


    REFERENCES
Top
Abstract
Text
References

1. Baranton, G., D. Postic, I. Saint Girons, P. Boerlin, J.-C. Piffaretti, M. Assous, and P. A. D. Grimont. 1992. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42:378-383[Abstract/Free Full Text].
2. Barbour, A. G. 1988. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J. Clin. Microbiol. 26:475-478[Abstract/Free Full Text].
3. Casjens, S., N. Palmer, R. van Vugt, W. M. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. M. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete, Borrelia burgdorferi. Mol. Microbiol. 35:490-516[CrossRef][Medline].
4. Dykhuizen, D. E., D. S. Polin, J. J. Dunn, B. Wilske, V. Preac-Mursic, R. J. Dattwyler, and B. J. Luft. 1993. Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc. Natl. Acad. Sci. USA 90:10163-10167[Abstract/Free Full Text].
5. Ferdows, M. S., P. Serwer, G. A. Griess, S. J. Norris, and A. G. Barbour. 1996. Conversion of a linear to a circular plasmid in the relapsing fever agent Borrelia hermsii. J. Bacteriol. 178:793-800[Abstract/Free Full Text].
6. Foretz, M., D. Postic, and G. Baranton. 1997. Phylogenetic analysis of Borrelia burgdorferi sensu stricto by arbitrarily primed PCR and pulsed-field gel electrophoresis. Int. J. Syst. Bacteriol. 47:11-18[Abstract/Free Full Text].
7. Fraser, C. M., S. Casjens, W. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J.-F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586[CrossRef][Medline].
8. Liveris, D., A. Gazumyan, and I. Schwartz. 1995. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 33:589-595[Abstract].
9. Liveris, D., S. Varde, R. Iyer, S. Koenig, S. Bittker, D. Cooper, D. McKenna, J. Nowakowski, R. B. Nadelman, G. P. Wormser, and I. Schwartz. 1999. Genetic diversity of Borrelia burgdorferi in Lyme disease patients determined by culture compared to direct polymerase chain reaction on clinical specimens. J. Clin. Microbiol. 37:565-569[Abstract/Free Full Text].
10. Liveris, D., G. P. Wormser, J. Nowakowski, R. Nadelman, S. Bittker, D. Cooper, S. Varde, F. H. Moy, G. Forseter, C. S. Pavia, and I. Schwartz. 1996. Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 34:1306-1309[Abstract].
11. Livey, I., C. P. Gibbs, R. Schuster, and F. Dorner. 1995. Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia. Mol. Microbiol. 18:257-269[CrossRef][Medline].
12. Marconi, R. T., D. S. Samuels, R. K. Landry, and C. F. Garon. 1994. Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange. J. Bacteriol. 176:4572-4582[Abstract/Free Full Text].
13. Mathiesen, D. A., J. H. Oliver, Jr., C. P. Kolbert, E. D. Tullson, B. J. Johnson, G. L. Campbell, P. D. Mitchell, K. D. Reed, S. R. Telford III, J. F. Anderson, R. S. Lane, and D. H. Persing. 1997. Genetic heterogeneity of Borrelia burgdorferi in the United States. J. Infect. Dis. 175:98-107[Medline].
14. Nadelman, R. B., J. Nowakowski, G. Forseter, N. S. Goldberg, S. Bittker, D. Cooper, M. Aguero-Rosenfeld, and G. P. Wormser. 1996. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am. J. Med. 100:502-508[CrossRef][Medline].
15. Nadelman, R. B., and G. P. Wormser. 1998. Lyme borreliosis. Lancet 352:557-565[CrossRef][Medline].
16. Orloski, K. A., E. B. Hayes, G. L. Campbell, and D. T. Dennis. 2000. Surveillance for Lyme disease---United States, 1992-1998. Morb. Mortal. Wkly. Rep. 49(SS-3):1-11[Medline].
17. Palmer, N., C. Fraser, and S. Casjens. 2000. Distribution of twelve linear extrachromosomal DNAs in natural isolates of Lyme disease spirochetes. J. Bacteriol. 182:2476-2480[Abstract/Free Full Text].
18. Schwan, T. G., W. Burgdorfer, and C. F. Garon. 1988. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect. Immun. 56:1831-1836[Abstract/Free Full Text].
19. Schwartz, I., G. P. Wormser, J. J. Schwartz, D. Cooper, P. Weissensee, A. Gazumyan, E. Zimmermann, N. S. Goldberg, S. Bittker, G. L. Campbell, and C. S. Pavia. 1992. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J. Clin. Microbiol. 30:3082-3088[Abstract/Free Full Text].
20. Simpson, W. J., C. F. Garon, and T. G. Schwan. 1990. Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi. Microb. Pathog. 8:109-118[CrossRef][Medline].
21. Walker, D. H., A. G. Barbour, J. H. Oliver, R. S. Lane, J. S. Dumler, D. T. Dennis, D. H. Persing, A. F. Azad, and E. McSweegan. 1996. Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA 275:463-469[Abstract/Free Full Text].
22. Wang, G., A. P. van Dam, and J. Dankert. 1999. Evidence for frequent OspC gene transfer between Borrelia valaisiana sp. nov. and other Lyme disease spirochetes. FEMS Microbiol. Lett. 177:289-296[CrossRef][Medline].
23. Wang, G., A. P. van Dam, I. Schwartz, and J. Dankert. 1999. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev. 12:633-653[Abstract/Free Full Text].
24. Wang, I., D. E. Dykhuizen, W. Qui, J. J. Dunn, E. M. Bosler, and B. J. Luft. 1999. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151:15-30[Abstract/Free Full Text].
25. Wormser, G. P., D. Liveris, J. Nowakowski, R. B. Nadelman, L. F. Cavaliere, D. McKenna, D. Holmgren, and I. Schwartz. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180:720-725[CrossRef][Medline].


Journal of Clinical Microbiology, August 2001, p. 2954-2957, Vol. 39, No. 8
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.8.2954-2957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rogers, E. A., Abdunnur, S. V., McDowell, J. V., Marconi, R. T. (2009). Comparative Analysis of the Properties and Ligand Binding Characteristics of CspZ, a Factor H Binding Protein, Derived from Borrelia burgdorferi Isolates of Human Origin. Infect. Immun. 77: 4396-4405 [Abstract] [Full Text]  
  • Stewart, P. E., Bestor, A., Cullen, J. N., Rosa, P. A. (2008). A Tightly Regulated Surface Protein of Borrelia burgdorferi Is Not Essential to the Mouse-Tick Infectious Cycle. Infect. Immun. 76: 1970-1978 [Abstract] [Full Text]  
  • Li, X., Neelakanta, G., Liu, X., Beck, D. S., Kantor, F. S., Fish, D., Anderson, J. F., Fikrig, E. (2007). Role of Outer Surface Protein D in the Borrelia burgdorferi Life Cycle. Infect. Immun. 75: 4237-4244 [Abstract] [Full Text]  
  • Terekhova, D., Iyer, R., Wormser, G. P., Schwartz, I. (2006). Comparative Genome Hybridization Reveals Substantial Variation among Clinical Isolates of Borrelia burgdorferi Sensu Stricto with Different Pathogenic Properties.. J. Bacteriol. 188: 6124-6134 [Abstract] [Full Text]  
  • Ojaimi, C., Mulay, V., Liveris, D., Iyer, R., Schwartz, I. (2005). Comparative Transcriptional Profiling of Borrelia burgdorferi Clinical Isolates Differing in Capacities for Hematogenous Dissemination. Infect. Immun. 73: 6791-6802 [Abstract] [Full Text]  
  • Dolan, M. C., Piesman, J., Schneider, B. S., Schriefer, M., Brandt, K., Zeidner, N. S. (2004). Comparison of Disseminated and Nondisseminated Strains of Borrelia burgdorferi Sensu Stricto in Mice Naturally Infected by Tick Bite. Infect. Immun. 72: 5262-5266 [Abstract] [Full Text]  
  • Ranka, R., Bormane, A., Salmina, K., Baumanis, V. (2004). Identification of Three Clinically Relevant Borrelia burgdorferi Sensu Lato Genospecies by PCR-Restriction Fragment Length Polymorphism Analysis of 16S-23S Ribosomal DNA Spacer Amplicons. J. Clin. Microbiol. 42: 1444-1449 [Abstract] [Full Text]  
  • Wang, G., Liveris, D., Brei, B., Wu, H., Falco, R. C., Fish, D., Schwartz, I. (2003). Real-Time PCR for Simultaneous Detection and Quantification of Borrelia burgdorferi in Field-Collected Ixodes scapularis Ticks from the Northeastern United States. Appl. Environ. Microbiol. 69: 4561-4565 [Abstract] [Full Text]  
  • Iyer, R., Kalu, O., Purser, J., Norris, S., Stevenson, B., Schwartz, I. (2003). Linear and Circular Plasmid Content in Borrelia burgdorferi Clinical Isolates. Infect. Immun. 71: 3699-3706 [Abstract] [Full Text]  
  • Ojaimi, C., Brooks, C., Casjens, S., Rosa, P., Elias, A., Barbour, A., Jasinskas, A., Benach, J., Katona, L., Radolf, J., Caimano, M., Skare, J., Swingle, K., Akins, D., Schwartz, I. (2003). Profiling of Temperature-Induced Changes in Borrelia burgdorferi Gene Expression by Using Whole Genome Arrays. Infect. Immun. 71: 1689-1705 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyer, R.
Right arrow Articles by Schwartz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyer, R.
Right arrow Articles by Schwartz, I.